Diagnosing and managing the patient with rosacea

Cutis

Volumn 75, Issue 4 SUPPL., 2005, Pages 25-29

  Mackley, Christine L ^a   Thiboutot, Diane M ^a,b  

^a PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

^b CollaGenex Pharmaceuticals Inc ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; AZITHROMYCIN; BENZOYL PEROXIDE; CLARITHROMYCIN; CLINDAMYCIN; COSMETIC; DIMETICONE; DOXYCYCLINE; ERYTHROMYCIN; IMIDAZOLE; ISOTRETINOIN; MACROLIDE; METRONIDAZOLE; MINOCYCLINE; OXYTETRACYCLINE; RETINOIC ACID; SULFACETAMIDE; SULFUR; TETRACYCLINE; TITANIUM DIOXIDE; ZINC OXIDE;

ACNE; CLINICAL TRIAL; DIAGNOSTIC PROCEDURE; DRUG HYPERSENSITIVITY; DRUG TOLERABILITY; GASTROINTESTINAL DISEASE; HUMAN; LOW LEVEL LASER THERAPY; REVIEW; ROSACEA; SKIN CARE; SKIN SURGERY; SURGICAL TECHNIQUE;

ADMINISTRATION, ORAL; ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; DRUG ADMINISTRATION ROUTES; FACIAL DERMATOSES; HUMANS; METRONIDAZOLE; ROSACEA; SKIN; SULFACETAMIDE; TREATMENT OUTCOME;

EID: 18244397717     PISSN: 00114162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (40)

1. Bikowski JB. Subantimicrobial dose doxycycline for acne and rosacea. Skinmed. 2003;2:234-245.
2. Cohen AF, Tiemstra JD. Diagnosis and treatment of rosacea. J Am Board Fam Pract. 2002;15:214-217.
3. Wilkin J, Dahl M, Detmar M, et al. Standard classification of rosacea: report of the National Rosacea Society Expert Committee on the Classification and Staging of Rosacea. J Am Acad Dermatol. 2002;46:584-587.
4. Crawford GH, Pelle MT, James WD. Rosacea: I. etiology, pathogenesis, and subtype classification. J Am Acad Dermatol. 2004;51:327-341.
5. Del Rosso JQ. Medical treatment of rosacea with emphasis on topical therapies. Expert Opin Pharmacother. 2004;5:5-13.
6. Marks R, Jones EW. Disseminated rosacea. Br J Dermatol. 1969;81:16-28.
7. Greaves MW, Burova E. Flushing: causes, investigation and clinical consequences. J Eur Acad Dermatol Venereol. 1997;8:91-100.
8. Higgins E, du Vivier A. Alcohol intake and other skin disorders. Clin Dermatol. 1999;17:437-441.
9. Wilkin JK. Oral thermal-induced flushing in erythematotelangiectatic rosacea. J Invest Dermatol. 1981;76:15-18.
10. Lonne-Rahm SB, Fischer T, Berg M. Stinging and rosacea. Acta Derm Venereol. 1999;79:460-461.
11. Jansen T, Plewig G. Clinical and histological variants of rhinophyma, including nonsurgical treatment modalities. Facial Plast Surg. 1998;14:241-253.
12. Akpek EK, Merchant A, Pinar V, et al. Ocular rosacea: patient characteristics and follow-up. Ophthalmology. 1997;104:1863-1867.
13. Ghanem VC, Mehra N, Wong S, et al. The prevalence of ocular signs in acne rosacea: comparing patients from ophthalmology and dermatology clinics. Cornea. 2003;22:230-233.
14. Draelos ZD. Silicones in topical dermatologic preparations. Cosmet Dermatol. January 2000;13:35-36.
15. Nichols K, Desai N, Lebwohl MG. Effective sunscreen ingredients and cutaneous irritation in patients with rosacea. Cutis. 1998;61:344-346.
16. Pelle MT, Crawford GH, James WD. Rosacea: II. therapy. J Am Acad Dermatol. 2004;51:499-512.
17. Miyachi Y. Potential antioxidant mechanism of action for metronidazole: implications for rosacea management. Adv Ther. 2001;18:237-243.
18. Breneman DL, Stewart D, Hevia O, et al. A double-blind, multicenter clinical trial comparing efficacy of once-daily metronidazole 1 percent cream to vehicle in patients with rosacea. Cutis. 1998;61:44-47.
19. Dahl MV, Jarratt M, Kaplan D, et al. Once-daily topical metronidazole cream formulations in the treatment of the papules and pustules of rosacea. J Am Acad Dermatol. 2001;45:723-730.
20. Lebwohl M, Medansky RS, Russo CL, et al. The comparative efficacy of sodium sulfacetamide 10%/sulfur 5% lotion (Sulfacet-R) and metronidazole 0.75% (MetroGel) in the treatment of rosacea. J Geriatr Dermatol. 1995;3:183-185.
21. Fitton A, Goa KL. Azelaic acid: a review of its pharmacological properties and therapeutic efficacy in acne and hyperpigmentary skin disorders. Drugs. 1991;41:780-798.
22. Maddin S. A comparison of topical azelaic acid 20% cream and topical metronidazole 0.75% cream in the treatment of patients with papulopustular rosacea. J Am Acad Dermatol. 1999;40(suppl 6, pt 1):961-965.
23. Gilchrest BA. Treatment of photodamage with topical tretinoin: an overview. J Am Acad Dermatol. 1997;36 (suppl 3, pt 2):S27-S36.
24. Wilkin JK. Rosacea. pathophysiology and treatment. Arch Dermatol. 1994;130:359-362.
25. Wilkin JK, DeWitt S. Treatment of rosacea: topical clindamycin versus oral tetracycline. Int J Dermatol. 1993;32:65-67.
26. Greenwald RA, Moak SA, Ramamurthy NS, et al. Tetracyclines suppress matrix metalloproteinase activity in adjuvant arthritis and in combination with flurbiprofen, ameliorate bone damage. J Rheumatol. 1992;19:927-938.
27. Torresani C, Pavesi A, Manara GC. Clarithromycin versus doxycycline in the treatment of rosacea. Int J Dermatol. 1997;36:942-946.
28. Torresani C. Clarithromycin: a new perspective in rosacea treatment. Int J Dermatol. 1998;37:347-349.
29. Baker O, Demircay Z, Gurbuz O. Therapeutic potential of azithromycin in rosacea. Int J Dermatol. 2004;43:151-154.
30. Saihan EM, Burton JL. A double-blind trial of metronidazole versus oxytetracycline therapy for rosacea. Br J Dermatol. 1980; 102:443-445.
31. Caro-Paton T, Carvasal A, Martin de Diego I, et al. Is metronidazole teratogenic? a meta-analysis. Br J Clin Pharmacol. 1997;44:179-182.
32. Marks R. Concepts in the pathogenesis of rosacea. Br J Dermatol. 1968;80:170-177.
33. Sneddon IB. A clinical trial of tetracycline in rosacea. Br J Dermatol. 1966;78:649-652.
34. Golub LM, Lee HM, Ryan ME, et al. Tetracyclines inhibit connective tissue breakdown by multiple non-antimicrobial mechanisms. Adv Dent Res. 1998;12:12-26.
35. Walker C, Thomas J, Nango S, et al. Long-term treatment with subantimicrobial dose doxycycline exerts no antibacterial effect on the subgingival microflora associated with adult periodontitis. J Periodontol. 2000;71:1465-1471.
36. Erdogan FG, Yurtsever P, Aksoy D, et al. Efficacy of low-dose isotretinoin in patients with treatment-resistant rosacea. Arch Dermatol. 1998;134:884-885.
37. Irvine C, Kumar P, Marks R. Isotretinoin in the treatment of rosacea and rhinophyma. In: Marks R, Plewig G, eds. Acne and Related Disorders: Proceedings of an International Symposium. London, England: Marin Dunitz; 1988:301-305.
38. Buscaglia DA, Conte ET. Successful treatment of generalized telangiectasia with the 585-nm flashlamp-pumped pulsed dye laser. Cutis. 2001;67:107-108.
39. Lonne-Rahm S, Nordlind K, Edstrom DW, et al. Laser treatment of rosacea: a pathoetiological study. Arch Dermatol. 2004;140:1345-1349.
40. Lloyd K. Surgical correction of rhinophyma. Arch Dermatol. 1990;126:721-723.